Duration of rapamycin treatment has differential effects on metabolism in mice

Cell Metabolism

Volumn 17, Issue 3, 2013, Pages 456-462

  Fang, Yimin ^a   Westbrook, Reyhan ^a   Hill, Cristal ^a   Boparai, Ravneet K ^a   Arum, Oge ^a   Spong, Adam ^a   Wang, Feiya ^a   Javors, Martin A ^b   Chen, Jie ^c   Sun, Liou Y ^a   Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; KETOGENESIS; LIFE EXTENSION; LIPID ANALYSIS; LIPID METABOLISM; LONGEVITY; MALE; METABOLIC PARAMETERS; METABOLISM; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOTTING, WESTERN; BODY COMPOSITION; CALORIMETRY, INDIRECT; ENERGY METABOLISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; INSULIN RESISTANCE; LONGEVITY; MICE; OXYGEN CONSUMPTION; SIROLIMUS; TIME FACTORS; TOR SERINE-THREONINE KINASES;

EID: 84875331396     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.02.008     Document Type: Article

References (22)

1. V.N. Anisimov, M.A. Zabezhinski, I.G. Popovich, T.S. Piskunova, A.V. Semenchenko, M.L. Tyndyk, M.N. Yurova, S.V. Rosenfeld, and M.V. Blagosklonny Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice Cell Cycle 10 2011 4230 4236
2. A. Bartke Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging Endocrinology 146 2005 3718 3723
3. N. Barzilai, D.M. Huffman, R.H. Muzumdar, and A. Bartke The critical role of metabolic pathways in aging Diabetes 61 2012 1315 1322
4. C.B. Blum Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model Am. J. Transplant. 2 2002 551 559
5. M.S. Bonkowski, F.P. Dominici, O. Arum, J.S. Rocha, K.A. Al Regaiey, R. Westbrook, A. Spong, J. Panici, M.M. Masternak, J.J. Kopchick, and A. Bartke Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity PLoS ONE 4 2009 e4567
6. G.R. Chang, Y.Y. Wu, Y.S. Chiu, W.Y. Chen, J.W. Liao, H.M. Hsu, T.H. Chao, S.W. Hung, and F.C. Mao Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice Basic Clin. Pharmacol. Toxicol. 105 2009 188 198
7. C. Chen, Y. Liu, Y. Liu, and P. Zheng mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells Sci. Signal. 2 2009 ra75
8. J.T. Cunningham, J.T. Rodgers, D.H. Arlow, F. Vazquez, V.K. Mootha, and P. Puigserver mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex Nature 450 2007 736 740
9. M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, and G. Leibowitz mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes Diabetes 57 2008 945 957
10. D.E. Harrison, R. Strong, Z.D. Sharp, J.F. Nelson, C.M. Astle, K. Flurkey, N.L. Nadon, J.E. Wilkinson, K. Frenkel, and C.S. Carter Rapamycin fed late in life extends lifespan in genetically heterogeneous mice Nature 460 2009 392 395
11. V.P. Houde, S. Brûlé, W.T. Festuccia, P.G. Blanchard, K. Bellmann, Y. Deshaies, and A. Marette Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue Diabetes 59 2010 1338 1348
12. K.J. Hughes, and B.K. Kennedy Cell biology. Rapamycin paradox resolved Science 335 2012 1578 1579
13. D.W. Lamming, L. Ye, P. Katajisto, M.D. Goncalves, M. Saitoh, D.M. Stevens, J.G. Davis, A.B. Salmon, A. Richardson, and R.S. Ahima Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity Science 335 2012 1638 1643
14. S. Li, M.S. Brown, and J.L. Goldstein Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis Proc. Natl. Acad. Sci. USA 107 2010 3441 3446
15. M. Matsumoto, S. Han, T. Kitamura, and D. Accili Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism J. Clin. Invest. 116 2006 2464 2472
16. M. Pende, S.H. Um, V. Mieulet, M. Sticker, V.L. Goss, J. Mestan, M. Mueller, S. Fumagalli, S.C. Kozma, and G. Thomas S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway Mol. Cell. Biol. 24 2004 3112 3124
17. P. Polak, N. Cybulski, J.N. Feige, J. Auwerx, M.A. Rüegg, and M.N. Hall Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration Cell Metab. 8 2008 399 410
18. M. Prentki, and S.R. Madiraju Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes Mol. Cell. Endocrinol. 353 2012 88 100
19. D.D. Sarbassov, S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, A.F. Bagley, A.L. Markhard, and D.M. Sabatini Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol. Cell 22 2006 159 168
20. C. Selman, J.M. Tullet, D. Wieser, E. Irvine, S.J. Lingard, A.I. Choudhury, M. Claret, H. Al-Qassab, D. Carmignac, and F. Ramadani Ribosomal protein S6 kinase 1 signaling regulates mammalian life span Science 326 2009 140 144
21. S. Sengupta, T.R. Peterson, M. Laplante, S. Oh, and D.M. Sabatini mTORC1 controls fasting-induced ketogenesis and its modulation by ageing Nature 468 2010 1100 1104
22. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471 484